Gushengtang Holdings Ltd
HKEX:2273
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
29.25
48.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Gushengtang Holdings Ltd
Cost of Revenue
Gushengtang Holdings Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Gushengtang Holdings Ltd
HKEX:2273
|
Cost of Revenue
-¥1.6B
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Cost of Revenue
-¥5.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Topchoice Medical Co Inc
SSE:600763
|
Cost of Revenue
-¥1.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-19%
|
|
|
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Cost of Revenue
-¥3.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-3%
|
|
|
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Cost of Revenue
-¥6.2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-24%
|
|
|
Jiangxi Rimag Group Co Ltd
HKEX:2522
|
Cost of Revenue
-¥596.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gushengtang Holdings Ltd
Glance View
Gushengtang Holdings Ltd. has woven itself into the fabric of China's healthcare system by focusing on traditional Chinese medicine (TCM), an industry deeply embedded in the nation's culture and ethos. The company operates a network of clinics that provide an array of services, from herbal medicine consultations to acupuncture treatments, leveraging China's growing demand for holistic healthcare solutions. By embracing both traditional practices and modern healthcare technologies, Gushengtang has positioned itself as a key player in delivering health services that resonate with a significant portion of the Chinese population who seek alternatives to Western medicine. Revenue streams for Gushengtang are multifaceted. The company earns primarily through the fees charged for consultations and treatments offered at its clinics, while also generating income from the sale of TCM products. Furthermore, by cultivating partnerships with health institutions and expanding its franchise network, Gushengtang enhances its reach and scalability. The integration of technology has allowed the firm to streamline operations and offer additional services like telemedicine, adapting to the digital shift in healthcare and tapping into the broader wellness market. This diversified approach not only fortifies its market position but ensures a steady flow of revenue in a competitive industry.
See Also
What is Gushengtang Holdings Ltd's Cost of Revenue?
Cost of Revenue
-1.6B
CNY
Based on the financial report for Dec 31, 2023, Gushengtang Holdings Ltd's Cost of Revenue amounts to -1.6B CNY.
What is Gushengtang Holdings Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-30%
Over the last year, the Cost of Revenue growth was -44%. The average annual Cost of Revenue growth rates for Gushengtang Holdings Ltd have been -49% over the past three years , -30% over the past five years .
You don't have any saved screeners yet